© Reuters. Viatris Earnings, Revenue miss in Q1
Investing.com – Viatris reported on Friday first quarter that missed analysts’ forecasts and revenue that fell short of expectations.
Viatris announced earnings per share of $1.08 on revenue of $3.62B. Analysts polled by Investing.com anticipated EPS of $1.24 on revenue of $4.17B.
Viatris shares are down 5.13% from the beginning of the year and are trading at $13.59 , down-from-52-week-high.They are under-performing the which is up 2.95% from the start of the year.
Viatris follows other major Healthcare sector earnings this month
Viatris’s report follows an earnings missed by Merck&Co on February 4, who reported EPS of $1.32 on revenue of $12.51B, compared to forecasts EPS of $1.38 on revenue of $12.67B.
Medtronic had beat expectations on February 23 with third quarter EPS of $1.29 on revenue of $7.78B, compared to forecast for EPS of $1.15 on revenue of $7.77B.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com’s earnings calendar
Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.